Medsider: Learn from MedTech and HealthTech Experts

In this episode of Medsider Radio, we sat down with Kelly Roman, co-founder and CEO of Fisher Wallace, a company spearheading the development of wearable brain stimulation technology aimed at providing relief from depression, anxiety, and insomnia. 

Kelly is a Harvard graduate with an English major who took an unconventional path to medtech inspired by his experience co-authoring the graphic novel adaptation of Sun Tzu's "The Art of War." He took a career leap from literature and marketing to pioneer a novel approach to the treatment of mental health. 

In this interview, we delve into what Kelly's learned on his journey, touching on the value of unconventional thinking, the importance of making mental health treatments more accessible and less stigmatized, and the potential of decentralized clinical trials.

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the recently launched Medsider Mentors Volume IV. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Kelly Roman.

In this episode of Medsider Radio, we had a chat with Dr. Alberto Rodriguez-Navarro, CEO of Levita Magnetics, a startup aiming to make surgical procedures as minimally invasive as possible with its advanced magnetic technology. 

Dr. Rodriguez-Navarro is not only a skilled surgeon but a medtech visionary with multiple patents to his name. Discover Alberto's journey spanning his childhood fascination with using magnets to clean the inside of his turtle tank to leveraging this concept into a cutting-edge magnetic surgery platform.  

In this interview,  Dr. Rodriguez-Navarro discusses what to consider when starting a new business, how to hone your framework when transitioning from the clinic, and early-stage strategies to ease the road to FDA approval.
 

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the recently launched Medsider Mentors Volume IV. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Dr. Rodriguez-Navarro.

In this episode of Medsider Radio, we sat down with Bill Colone, the CEO and Chairman of SinglePass, a company developing an electrocautery device for deep tissue biopsies.

Bill previously headed Spinal Singularity, raising over $11 million for product and clinical development. He was VP of R&D at Direct Flow Medical and the President of Endomed, which was sold in 2005. Bill also served in multiple leadership roles at Endologix and holds 13 U.S. patents with more pending. He earned his bachelor's in Chemical Engineering from Arizona State University, where he later served as an Associate Faculty Member and sits on the advisory committee for Chemical and Materials Engineering.

In this interview, Bill shares invaluable insights and actionable strategies for building and leveraging an expansive network, optimizing fundraising, and strategically planning for both acquisition and independent growth.
 

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the recently launched Medsider Mentors Volume IV. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Bill Colone.

In this episode of Medsider Radio, we sat down with Shyam Natarajan, founder and CEO of Avenda Health, which utilizes artificial intelligence and cutting-edge imaging to improve the diagnosis and treatment of prostate cancer.

After getting his PhD in Biomedical Engineering from UCLA, Shyam worked as a postdoctoral scholar in UCLA's Department of Surgery, focusing on minimally invasive surgical interventions. He also managed the UCLA Business of Science Center, spearheading initiatives to guide students toward non-academic career paths. With experiences like founding UCLA Innovation Week and the Inventathon, he is committed to pushing the boundaries of medical technology. At Avenda Health, Shyam is now leading the charge in revolutionizing prostate cancer care. 

In this interview, we talk about what it really takes to understand the market need for your product or service, how prototypes can be incredibly helpful in convincing relevant parties, how Shyam approaches fundraising, and what to expect from medtech in the future given current technological advancements in growing fields like AI.
 

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the recently launched Medsider Mentors Volume IV. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Shyam Natarajan.

In this episode of Medsider Radio, we sat down with Dr. David Albert, founder of AliveCor, which is pioneering the standard for personal ECG devices that extend beyond hardware and encompass services and partnerships to offer comprehensive personal cardiovascular solutions.

Dr. Albert is a multifaceted individual — a physician, scientist, inventor, serial entrepreneur, YouTube sensation, and even an adventurous surfer. His academic journey led him from Duke University, where he completed both engineering and medical graduate studies, back to his roots at the University of Oklahoma. He already had several licensed inventions when he decided to stake it all on a new cardiovascular device. The gamble led him to found AliveCor, now a frontrunner in personal electrocardiograms (ECGs) under the renowned Kardia brand. 

In this interview, we take a tour down the lanes of innovation, prototyping, fundraising, and why sometimes you have to ditch the white coat to take your ideas from the lab to the real world.

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Dr. Albert.

In this episode of Medsider Radio, we sat down with Parag Gad, who founded SpineX to turn cutting-edge science into life-changing devices. The FDA has granted Breakthrough Device Designation for two of SpineX's non-invasive products aimed at improving the lives of adults with neurogenic bladder conditions and children with cerebral palsy.

Parag understands both sides of the coin — the research-intensive academic world and the rigorous standards of healthcare regulation. With SpineX, he's marrying the two, aiming for a transformation in spinal healthcare. The company has raised $3.6 million in equity financing and has also secured non-dilutive funding from government agencies. With ongoing multicenter clinical trials and plans for future enrollment, Parag is steering SpineX toward a new frontier in bioelectric medicine.

In this interview, Parag delves into the intricate journey of transitioning from academia to entrepreneurship, securing non-traditional funding, and the role of regulatory milestones in building a reputable healthcare brand.

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Parag Gad.

In this episode of Medsider Radio, we sat down with Kirsten Carroll, CEO of Kandu Health, and a medtech veteran specializing in neurovascular disorders with nearly 25 years of experience in the field. 

Kirsten holds a degree in biomedical engineering and dual master's degrees in business and public health. She has held strategic roles at industry leaders like Boston Scientific and Stryker before joining Imperative Care and co-founding Kandu Health. Her startup focuses on revolutionizing post-stroke care and enhancing the quality of life for stroke survivors through tech-enabled healthcare services.

In this interview, Kirsten talks about redefining post-stroke care with a comprehensive set of services to improve the well-being of stroke survivors and, consequently, their care partners. From her unique perspective on innovation to her emphasis on a multi-stakeholder approach, Kirsten shares invaluable lessons on breaking down monumental challenges and fostering a culture of teamwork.

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Kirsten Carroll.

In this episode of Medsider Radio, we sat down with Gabriel Jones, co-founder and CEO of Proprio, who has had a career spanning engineering, law, finance, and philanthropy across the world. 

Gabriel studied engineering at the University of Washington before furthering his career at Tase Kensetsu, a major civil engineering and manufacturing firm in Japan. He then moved to Wall Street to work on large-scale mergers and acquisitions for high-profile clients like AT&T and Google. After returning to Seattle, Gabriel collaborated with the Bill & Melinda Gates Foundation on global healthcare initiatives. Today, he is the CEO of Proprio, a revolutionary medtech startup aiming to improve surgical precision with AI-powered technology.

In this interview, the eclectic Gabriel shares how his background has equipped him with a unique framework for creating a thriving startup ecosystem, tips on capital fundraising, and using public relations to his favor.

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor! 

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Gabriel Jones.

In this episode of Medsider Radio, we pull back the curtain on L.R. Fox, the visionary founder of NEXT Life Sciences. With an ambitious mission to democratize family planning, Fox and his team are on the brink of launching their flagship product, Plan A— a groundbreaking male contraceptive.

Before founding NEXT Life Sciences, Fox was already a powerhouse entrepreneur in numerous highly regulated industries ranging from cybersecurity to aerospace, including WhiteFox Defense Technologies, a company that is shaping the future of drone airspace security. With a degree in engineering and as a member of the Forbes' 30 Under 30 list in 2019., Fox is currently leading NEXT’s efforts to introduce Plan A to the market. 

In this interview, Fox shares invaluable lessons on fostering collaboration in a competitive space, understanding key stakeholders, and the art of raising capital. Whether you're an aspiring entrepreneur or simply curious about how innovation can drive societal change, this conversation offers key takeaways for all.

Before we dive into the discussion, I wanted to mention a few things:

If you’re into learning from proven medtech and health tech leaders and want to know when new content and interviews go live, head over to Medsider.com and sign up for our free newsletter. You’ll get access to gated articles, and lots of other interesting healthcare content.

Second, if you want even more inside info from proven experts, think about a Medsider premium membership. We talk to experienced life science leaders about the nuts and bolts of running a business and bringing products to market.

This is your place for valuable knowledge on specific topics like seed funding, prototyping, insurance reimbursement, and positioning a medtech startup for an exit.

In addition to the entire back catalog of Medsider interviews over the past decade, premium members get a copy of every volume of Medsider Mentors at no additional cost. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd much rather read, here's a link to the full interview with L.R. Fox.

In this episode of Medsider Radio, we sat down with Sean Morris, CEO of Amplifi, developers of the groundbreaking Vein Dilation System to improve access sites for dialysis patients.

Sean started his professional journey selling medical devices for AngioDynamics. Over his ten-year tenure with the company, Sean rose through the ranks to become the Global Vice President of Marketing and later led the entire Peripheral Vascular Division. After leaving AngioD in 2009, he embarked on various entrepreneurial ventures, including the founding of Veniti, which was acquired by Boston Scientific in 2018. He also spearheaded Euphrates Vascular, an innovative startup in the field of microvascular obstructions.

In this interview,  Sean shares the story — from his first job selling medical devices for AngioDynamics to his current role as CEO of Amplifi, how his novel Vein Dilation System is poised to revolutionize dialysis patient care, and the many lessons he’s learned bringing innovative medtech products to market as a startup CEO.

Before we dive into the discussion, I wanted to mention a few things:

If you’re into learning from proven medtech and health tech leaders and want to know when new content and interviews go live, head over to Medsider.com and sign up for our free newsletter. You’ll get access to gated articles, and lots of other interesting healthcare content.

Second, if you want even more inside info from proven experts, think about a Medsider premium membership. We talk to experienced life science leaders about the nuts and bolts of running a business and bringing products to market.

This is your place for valuable knowledge on specific topics like seed funding, prototyping, insurance reimbursement, and positioning a medtech startup for an exit.

In addition to the entire back catalog of Medsider interviews over the past decade, premium members get a copy of every volume of Medsider Mentors at no additional cost. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd much rather read, here's a link to the full interview with Sean Morris.

In this episode of Medsider Radio, we sat down with Dr. Krishan Ramdoo, the CEO and creative mind behind the Tympa platform, an all-in-one ear and hearing health assessment system that has gained global recognition.

Dr. Ramdoo is a celebrated international speaker, researcher, and educator with a keen focus on the intersection of medical science and technology. Some of the accolades Dr. Ramdoo and the Tympa team have received include the prestigious Royal Society of Medicine prize for innovation in ENT, the Rowena Ryan prize for research into ENT, and the Hartopp-Dixon ENT award.

In this interview, he talks about his journey toward becoming a technology innovator, starting as an ENT physician to eventually developing the Tympa platform. Dr. Ramdoo shares invaluable insights on the importance of patient-centric problem-solving, balancing external feedback with personal vision, and the power of tangible products in converting stakeholders to true believers in your solution.

Before we dive into the discussion, I wanted to mention a few things:

If you’re into learning from proven medtech and health tech leaders and want to know when new content and interviews go live, head over to Medsider.com and sign up for our free newsletter. You’ll get access to gated articles, and lots of other interesting healthcare content.

Second, if you want even more inside info from proven experts, think about a Medsider premium membership. We talk to experienced life science leaders about the nuts and bolts of running a business and bringing products to market.

This is your place for valuable knowledge on specific topics like seed funding, prototyping, insurance reimbursement, and positioning a medtech startup for an exit.

In addition to the entire back catalog of Medsider interviews over the past decade, premium members get a copy of every volume of Medsider Mentors at no additional cost. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, here's a link to the full interview with Dr. Ramdoo if you prefer to read it.

In this episode of Medsider Radio, we sat down with Allison London Brown, CEO of Luminelle, who has over 25 years of experience in the healthcare space and has been involved in nearly every aspect of product development for women's health.

From Fortune 50 companies like Johnson & Johnson and GE Healthcare to founding startups, Allison has seen it all. Now, as the CEO and co-founder of Luminelle, she's channeling her decades of knowledge into a revolutionary new device aiming to transform gynecological procedures.

In this interview, Allison shares insights on how to best understand your strengths and weaknesses, the potential pitfalls of 'one size fits all' regulatory strategies, and innovative methods to secure capital in a risk-averse economy. 

Before we dive into the discussion, I wanted to mention a few things:

If you’re into learning from proven medtech and health tech leaders and want to know when new content and interviews go live, head over to Medsider.com and sign up for our free newsletter. You’ll get access to gated articles, and lots of other interesting healthcare content.

Second, if you want even more inside info from proven experts, think about a Medsider premium membership. We talk to experienced life science leaders about the nuts and bolts of running a business and bringing products to market.

This is your place for valuable knowledge on specific topics like seed funding, prototyping, insurance reimbursement, and positioning a medtech startup for an exit.

In addition to the entire back catalog of Medsider interviews over the past decade, premium members get a copy of every volume of Medsider Mentors at no additional cost. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, here's a link to the full interview with Allison if you prefer reading.

In this episode of Medsider Radio, we sat down with David Narrow, CEO of Sonavex, who has previously worked with multinational medical device companies on their commercialization and long-term business strategies as a healthcare consultant for Health Advances. 

David earned his B.S. in Biomedical Engineering with Highest Distinction from the University of Rochester before receiving his Masters from Johns Hopkins University. He was named 30 Under 30 in Healthcare by Forbes in 2016 and 40 Under 40 by the Baltimore Business Journal in 2017.

In this interview with David, we talk about the art of perfecting product design, the strategies to adeptly navigate complex regulatory waters, and the nuances of capturing the trust and interest of venture capitalists. 

Before we dive into the discussion, I wanted to mention a few things:

If you’re into learning from proven medtech and health tech leaders and want to know when new content and interviews go live, head over to Medsider.com and sign up for our free newsletter. You’ll get access to gated articles, and lots of other interesting healthcare content.

Second, if you want even more inside info from proven experts, think about a Medsider premium membership. We talk to experienced life science leaders about the nuts and bolts of running a business and bringing products to market.

This is your place for valuable knowledge on specific topics like seed funding, prototyping, insurance reimbursement, and positioning a medtech startup for an exit.

In addition to the entire back catalog of Medsider interviews over the past decade, premium members get a copy of every volume of Medsider Mentors at no additional cost. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, here's a link to the full interview with David if you prefer reading.

In this episode of Medsider Radio, we sat down with Shriram Raghunathan, a neuroengineering pioneer and CEO of Noctrix Health.

Shri has been leading his team in the development of innovative solutions to improve the lives of patients with neurological disorders like restless leg syndrome, aiming to level the playing field between medical devices and pharmaceuticals in patient care.

In this interview, Shri talks about how a mindset of exploration has driven his venture into the development of novel medical solutions within the challenging terrain of neurology. He also offers valuable insights on the critical importance of focusing on unmet needs, building a high-performance team, and navigating regulatory and capital-raising challenges. 

Before we jump into the conversation, I wanted to mention a few things:

If you’re into learning from proven medtech and health tech leaders and want to know when new content and interviews go live, head over to Medsider.com and sign up for our free newsletter. You’ll get access to gated articles, and lots of other interesting healthcare content.

Second, if you want even more inside info from proven experts, think about a Medsider premium membership. We talk to experienced life science leaders about the nuts and bolts of running a business and bringing products to market.

This is your place for valuable knowledge on specific topics like seed funding, prototyping, insurance reimbursement, and positioning a medtech startup for an exit.

In addition to the entire back catalog of Medsider interviews over the past decade, premium members get a copy of every volume of Medsider Mentors at no additional cost. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, here's a link to the full interview with Shriram if you prefer reading.

In this episode of Medsider Radio, we sat down with Kate Rumrill, CEO of Ablative Solutions, a clinical-stage medical device startup specializing in transcatheter perivascular alcohol denervation for hypertension.

Kate is an accomplished leader with over three decades of comprehensive experience within the medtech and pharmaceutical industries. She brings a unique blend of expertise to the table, spanning roles from clinical affairs to executive management, with pivotal stints at prominent companies such as Eli Lilly and Covidien.

Her journey from being an aspiring neurosurgeon to leading a life sciences startup underscores the power of seizing unexpected opportunities. In this interview, Kate dives into her three-decade-long career and provides valuable lessons on the importance of thorough research, strategic clinical trial design, and effective reimbursement strategies.

Before we jump into the conversation, I wanted to mention a few things:

If you’re into learning from proven medtech and health tech leaders and want to know when new content and interviews go live, head over to Medsider.com and sign up for our free newsletter. You’ll get access to gated articles, and lots of other interesting healthcare content.

Second, if you want even more inside info from proven experts, think about a Medsider premium membership. We talk to experienced life science leaders about the nuts and bolts of running a business and bringing products to market.

This is your place for valuable knowledge on specific topics like seed funding, prototyping, insurance reimbursement, and positioning a medtech startup for an exit.

In addition to the entire back catalog of Medsider interviews over the past decade, premium members get a copy of every volume of Medsider Mentors at no additional cost. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, here's a link to the full interview with Kate if you prefer reading.

In this episode of Medsider Radio, we sat down with Lloyd Diamond, CEO of Pixium Vision a company that is developing a groundbreaking retinal implant system for patients suffering from advanced dry age-related macular degeneration (dry AMD).

Lloyd has a rich history of guiding medtech and biotech companies. His career spans decades, continents, and sectors, and he has been actively involved in both European and American markets. His experiences with large strategic firms and promising startups have equipped him with a unique entrepreneurial viewpoint. 

In this interview, Lloyd shares practical lessons on building a lean and adaptable team, navigating the intricacies of regulatory processes, and succeeding at strategic fundraising. His insights, drawn from hands-on experience, provide actionable advice for startups making their way in the challenging medtech landscape.

Before we jump into the conversation, I wanted to mention a few things:

If you’re into learning from proven medtech and health tech leaders and want to know when new content and interviews go live, head over to Medsider.com and sign up for our free newsletter. You’ll get access to gated articles, and lots of other interesting healthcare content.

Second, if you want even more inside info from proven experts, think about a Medsider premium membership. We talk to experienced life science leaders about the nuts and bolts of running a business and bringing products to market.

This is your place for valuable knowledge on specific topics like seed funding, prototyping, insurance reimbursement, and positioning a medtech startup for an exit.

In addition to the entire back catalog of Medsider interviews over the past decade, premium members get a copy of every volume of Medsider Mentors at no additional cost. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, here's a link to the full interview with Lloyd if you prefer reading.

In this episode of Medsider Radio, we sat down with Craig Davis, CEO of NovaScan, a company revolutionizing cancer diagnostics with a low-cost, single-use device capable of real-time cancer detection and stratification.

Craig is a strategist, entrepreneur, and leader with a resume boasting a unique blend of business acumen, investment insight, and technical expertise. 

In this interview, Craig unveils his journey from being a partner at LaSalle Investments to leading the charge in revolutionizing cancer diagnostics. He delves into the myriad of challenges entrepreneurs face, like fostering efficient early-stage development, designing clinical trials for rapid data collection, and mastering the art of fundraising in an ever-evolving financial landscape. 

Before we jump into the conversation, I wanted to mention a few things:

If you’re into learning from proven medtech and health tech leaders and want to know when new content and interviews go live, head over to Medsider.com and sign up for our free newsletter. You’ll get access to gated articles, and lots of other interesting healthcare content.

Second, if you want even more inside info from proven experts, think about a Medsider premium membership. We talk to experienced life science leaders about the nuts and bolts of running a business and bringing products to market.

This is your place for valuable knowledge on specific topics like seed funding, prototyping, insurance reimbursement, and positioning a medtech startup for an exit.

In addition to the entire back catalog of Medsider interviews over the past decade, premium members get a copy of every volume of Medsider Mentors at no additional cost. If you’re interested, go to medsider.com/subscribe to learn more.

In this episode of Medsider Radio, we sat down with Brett Wingeier, co-founder and CTO of Magnus Medical, a privately held medical device company whose FDA-cleared SAINT™ Neuromodulation System aims to revolutionize mental health care. 

Brett is a prominent figure in neuromodulation, leveraging his expertise in medicine, biology, and engineering to advance the arena within medtech. He was part of the pioneering team at NeuroPace and also co-founded Halo Neuroscience. 

In this interview, Brett shares valuable insights into understanding the system you're working with, balancing consumer and provider perspectives, and ensuring cost-effectiveness for successful reimbursement.

Before we jump into the conversation, I wanted to mention a few things:

If you’re into learning from proven medtech and health tech leaders and want to know when new content and interviews go live, head over to Medsider.com and sign up for our free newsletter. You’ll get access to gated articles, and lots of other interesting healthcare content.

Second, if you want even more inside info from proven experts, think about a Medsider premium membership. We talk to experienced life science leaders about the nuts and bolts of running a business and bringing products to market.

This is your place for valuable knowledge on specific topics like seed funding, prototyping, insurance reimbursement, and positioning a medtech startup for an exit.

In addition to the entire back catalog of Medsider interviews over the past decade, premium members get a copy of every volume of Medsider Mentors at no additional cost. If you’re interested, go to medsider.com/subscribe to learn more.

In this episode of Medsider Radio, we sat down with Mara McFadden CEO of Endolumik, developers of an innovative fluorescence-guided esophagogastric calibration system. 

Mara graduated as a mechanical engineer from the University of California, Berkeley. She further developed her business acumen during her MBA at Carnegie Mellon University and in various leadership positions with renowned healthcare companies such as Johnson & Johnson and Philips Healthcare. 

Mara co-founded Endolumik, and in this interview, shares her philosophy of embracing imperfections and learning from your failures, why customer engagement and team culture are integral to business growth, and how the art of smart fundraising can lead to a thriving venture.

Before we jump into the conversation, I wanted to mention a few things:

If you’re into learning from proven medtech and health tech leaders and want to know when new content and interviews go live, head over to Medsider.com and sign up for our free newsletter. You’ll get access to gated articles, and lots of other interesting healthcare content.

Second, if you want even more inside info from proven experts, think about a Medsider premium membership. We talk to experienced life science leaders about the nuts and bolts of running a business and bringing products to market.

This is your place for valuable knowledge on specific topics like seed funding, prototyping, insurance reimbursement, and positioning a medtech startup for an exit.

In addition to the entire back catalog of Medsider interviews over the past decade, premium members get a copy of every volume of Medsider Mentors at no additional cost. If you’re interested, go to medsider.com/subscribe to learn more.

In this episode of Medsider Radio, we sat down with Joe Rafferty CEO of Vesteck, a developer of medical devices intended to treat patients diagnosed with aortic aneurysms.

Joe is a seasoned executive with a wealth of experience designing, building, and commercializing medical devices. In this conversation, Joe shares his storied journey in the medtech space, from his broad experiences within the cardiovascular arena to his current role leading Vesteck. Joe offers valuable insights on building a high-functioning in-house team, raising capital, and tips for ensuring your commercial launches are successful.

Before we jump into the conversation, I wanted to mention a few things:

If you’re into learning from proven medtech and health tech leaders and want to know when new content and interviews go live, head over to Medsider.com and sign up for our free newsletter. You’ll get access to gated articles, and lots of other interesting healthcare content.

Second, if you want even more inside info from proven experts, think about a Medsider premium membership. We talk to experienced life science leaders about the nuts and bolts of running a business and bringing products to market.

This is your place for valuable knowledge on specific topics like seed funding, prototyping, insurance reimbursement, and positioning a medtech startup for an exit.

In addition to the entire back catalog of Medsider interviews over the past decade, premium members get a copy of every volume of Medsider Mentors at no additional cost. If you’re interested, go to medsider.com/subscribe to learn more.